Immix Biopharma, Inc.

Historical 13F Holders

Symbol
IMMX
CUSIP
45258H106
All holders as of
Q2 2026
Type
Equity
Class
COM
Reported Value, Excluding Options
Total Filings

13D/G Filers

Investors who own more than 5% of a class must file a Schedule 13D or 13G. Every filing for 45258H106 since 12/18/2024, newest first.

Filer % of Class Filed
Eventide Asset Management, LLC 13G
5.6% 8/14/2026
Event 6/30/2026
Janus Henderson Group Ltd. 13G/A Amendment 3 14.0% 8/13/2026
Event 6/30/2026
Janus Henderson Group PLC 13G/A Amendment 2 13.0% 6/5/2026
Event 5/29/2026
Janus Henderson Group PLC 13G/A Amendment 1 9.1% 5/15/2026
Event 3/31/2026
Millennium Management LLC 13G/A Amendment 1
3.3% 5/4/2026
Event 3/31/2026
Millennium Management LLC 13G
5.3% 3/20/2026
Event 3/13/2026
Janus Henderson Group PLC 13G 7.4% 2/17/2026
Event 12/31/2025
Saturn V Capital Management LP 13G
7.0% 2/17/2026
Event 12/26/2025
Orin Hirschman 13G/A Amendment 1
0% 1/29/2025
Event 12/31/2024

13F Holders by Quarter

Period Filings Shares, Excl. Options Value, Excl. Options
2026 Q3 3 828 $8.62 k
2026 Q2 113 56.2 M $580 M
2026 Q1 79 27.1 M $247 M
2025 Q4 69 24.4 M $127 M
2025 Q3 31 2.77 M $5.78 M
2025 Q2 25 2.27 M $4.71 M
2025 Q1 23 2.92 M $4.90 M
2024 Q4 27 2.88 M $6.34 M
2024 Q3 28 4.09 M $6.10 M
2024 Q2 33 4.49 M $8.89 M
2024 Q1 39 5.21 M $16.1 M
2023 Q4 32 800 k $5.44 M
2023 Q3 17 405 k $1.39 M
2023 Q2 19 656 k $1.75 M
2023 Q1 13 401 k $730 k
2022 Q4 20 484 k $1.11 M
2022 Q3 13 300 k $406 k
2022 Q2 8 183 k $475 k
2022 Q1 9 147 k $352 k
2021 Q4 12 1.54 M $5.47 M